FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Tuesday

 

19 ARTICLES & STUDIES IN TODAY'S NEWS FOR NEUROLOGISTS, NURSES & PATIENTS! 5,166 MS HEADLINES ARE IN OUR ARCHIVES! MORE DAILY MS NEWS THAN ANY SITE IN THE WORLD!

 Use of a biomarker in exposure-response analysis to support dose selection for fingolimod.

Patient-related factors may affect the outcome of neuropsychological rehabilitation in multiple sclerosis.
Patient-related factors affected rehabilitation outcome, whereas illness- and intervention-related factors did not. The results showed that especially MS patients with male gender and more severe attentional deficits benefitted from the intervention (attention retraining, teaching compensatory strategies, psychoeducation, psychological support, and homework assignments).

Anti-JCV antibody prevalence in a French cohort of MS patients under natalizumab therapy.

Prolonged and symptomatic bradycardia following a single dose of GILENYA

CLICK ON "Read More" FOR THE REMAINING 10 STUDIES & ARTICLES  


CLINICAL TRIAL: Investigators Recruiting For Study of Lower Dose of Gilenya Versus Copaxone In MS

 Information on Current and Completed Pregnancy Registries for MS Therapies

(VIDEO) A Summer Spent At MS Center Offers Insight Into Mom's Battle



T-cell homeostasis in pediatric multiple sclerosis: Old cells in young patients

Premature immune senescence in children with MS: Too young to go steady

Glatiramer acetate–induced acute hepatotoxicity in an adolescent with MS

Cerebrospinal fluid derived immunoglobulin G of different multiple sclerosis patients share mutated sequences in complementarity determining regions.

The impact of diagnostic criteria for neuromyelitis optica in patients with MS: a 10-year follow-up of the South Atlantic Project.

Application and a proposed modification of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromes.

Paroxysmal ataxia and dysarthria in multiple sclerosis.

Evidence against the Involvement of Chronic Cerebrospinal Venous Abnormalities in Multiple Sclerosis. A Case-Control Study.

Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials.

Genetic variation near IRF8 is associated with serologic and cytokine profiles in systemic lupus erythematosus and multiple sclerosis.

Health plan utilization and costs of specialty drugs within Multiple Sclerosis

Labels: ,



Go to Newer News Go to Older News